AUG 29, 2016 3:02 PM PDT

EpiPen Maker Announces Generic Version Amid Public Fury

WRITTEN BY: Xuan Pham
Mylan, makers of the famed EpiPen recently came under public fire for increasing the price of its life-saving device to over 500 percent. Relenting to intense pressure, the manufacturer issued vouchers intended to slash some out-of-pocket costs for consumers. Now, in its latest attempt to appease consumers and lawmakers, Mylan announced the launch of a generic version of the EpiPen priced at half of its brand-name product.
 
This brouhaha is the latest example of what critics are calling as blatant drug price hikes by the “big pharma.” Earlier this year, Turing Pharmaceuticals was heavily criticized for changing the price of a drug, Daraprim, from $13.50 to a whopping $750 per tablet. By comparison, the price hike for the EpiPen isn’t as bad, but it’s still significant and cost-prohibitive for consumers. In 2007, Mylan charged around $100 for a 2-pack of the EpiPens; now, the price has soared to over $600.
 
To be sure, no one is debating the medical importance of the EpiPen. These are classified as epinephrine auto-injectors that can mean the difference between life and death for people who have severe anaphylactic reactions. What people are outraged by is the seemingly insensible price boost.
 
It also didn’t pass notice that the CEO of Mylan, Heather Bresch, received a particularly enormous salary bump in the same time frame (from $2.5 million to close to $19 million annually). It was also Bresch who intensely led the lobbying campaign that required schools to have EpiPens available for students.
 
 The price hike got the attention of Senator Charles Grassley who formally asked Mylan to explain their pricing.
 
In response, Mylan cited the high costs of lobbying efforts and the changing structure of insurance plans. "Because of the complexity and opaqueness of today's branded pharmaceutical supply chain and the increased shifting of costs to patients as a result of high deductible health plans, we determined that bypassing the brand system in this case and offering an additional alternative was the best option," said Bresch in a statement.
 
But no one is buying it.
 
To alleviate the pressure, Mylan tried to offer vouchers for the brand-name devices. But critics say this tactic does nothing to lower the actual cost of the EpiPens for insurers and other entities.
 

And now comes the announcement of a cheaper, generic alternative of the EpiPens … by none other than Mylan itself. "The weirdness of a generic drug company offering a generic version of its own branded but off-patent product is a signal that something is wrong," said Robert Weissman, president of the consumer group Public Citizen. This is to say critics see Mylan’s generics as still a masked form of price-gouging.
 
The furor over Mylan and the EpiPen has the potential to spill over to other manufacturers and drugs/devices. Perhaps then this could be the stimulus for more transparency between drug manufacturers, policy makers, and the consumer.
 
Additional sources: NPR, StatNews
About the Author
I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
FEB 03, 2022
Clinical & Molecular DX
Time of Day May Affect Chemo Potency
FEB 03, 2022
Time of Day May Affect Chemo Potency
Brain tumors are associated with low survival rates for a number of reasons. For one, malignant brain tumors o ...
FEB 24, 2022
Cardiology
Light Drinking is Harmful to the Heart
FEB 24, 2022
Light Drinking is Harmful to the Heart
Even small amounts of alcohol appear to increase the risk of cardiovascular events.
MAR 18, 2022
Clinical & Molecular DX
Study Indicates Possible Links between Suicide and Undiagnosed Autism
MAR 18, 2022
Study Indicates Possible Links between Suicide and Undiagnosed Autism
The American Foundation for Suicide Prevention reports that over 45,000 Americans died by suicide in 2020, mak ...
APR 12, 2022
Cardiology
What Happens During a Heart Attack?
APR 12, 2022
What Happens During a Heart Attack?
Knowing could save your life.
APR 27, 2022
Clinical & Molecular DX
Asthma Risk Increased in Children Conceived with Infertility Treatment
APR 27, 2022
Asthma Risk Increased in Children Conceived with Infertility Treatment
Asthma is a disease characterized by difficulty breathing, and an asthma attack can bring on bouts of coughing and wheez ...
MAY 16, 2022
Cell & Molecular Biology
How To Ensure You Are Using High Quality Laboratory Consumables That Produce Consistent Results
MAY 16, 2022
How To Ensure You Are Using High Quality Laboratory Consumables That Produce Consistent Results
There are many important considerations when choosing your laboratory consumables. How do you know that the plastic labw ...
Loading Comments...